Management Team

Keith Rubin, M.D.
Founder and Chief Executive Officer
Ken Solovay
Chief Operating Officer
Stephanie Noviello, M.D., M.P.H.
Chief Medical Officer
Luis Rios-Nogales, M.D., Ph.D., M.B.A.
Executive VP and Chief Development Officer

André Morais Campos
Vice-President, Global Clinical Operations
Marcel Thalen, Ph.D.
Vice-President, Drug Product Development
Stanley Kim, Ph.D., Esq.
Senior Vice President, Intellectual Property and Contracts

Peter Goldstein
Executive Director, Vaccine Platform Development
Ana Keiko Sekine
Executive Director, Global Clinical Operations.
Luciana da Silva Meira Butera
Associate Manager, Clinical Process Excellence
Theressa Creighton
Senior Clinical Project Manager

Steve Glazer, M.D.
Director, New Research Programs
Walter Greenblatt
Corporate Development
Jim Ramadei
Matthew Bross
Administrative Manager

Copyright 2013-2023 ILiAD Biotechnologies
Financial Conflict of Interest (FCOI) Policy